KYMR
KYMR
NASDAQ · Biotechnology

Kymera Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$86.08
+1.45 (+1.71%)
As of May 9, 1:15 AM ET ·
Analyst Consensus
Strong Buy
29
Analysts
High
Coverage
Buy 27 93%
Hold 2 7%
Sell 0 0%
Price Target
Analyst Price Target -64.0% upside
Low Target $20.33
Average Target $31.03
High Target $33.62
Current Price $86.08
Current
$86.08
Target
$31.03
$20.33 $31.03 avg $33.62
Scenario Analysis
Bear Case
$20.33
-76.4%
Low target
Base Case
$31.03
-64.0%
Avg target
Bull Case
$33.62
+-60.9%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$103.00
-16.4% from high
52-Week Low
$28.06
+206.8% from low
50-Day SMA
$78.66
+9.4% vs SMA
200-Day SMA
$56.03
+53.6% vs SMA
RSI (14)
77.3
Overbought
Target vs 52W High
$31.03
-69.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%